Nitrile gloves: Gloves reduce direct contact contamination, but only if you avoid touching nonsterile surfaces once they are on
Because semaglutide works by activating GLP-1 receptors that regulate satiety and glucose metabolism, once the medication clears your system (it has a one-week half-life), your brain no longer receives the same appetite-suppressing signals

Based on the clinical trial population and the medications mechanism, individuals who may benefit most from retatrutide once it becomes available include: Adults with a BMI of 30 or greater (obesity) Adults with a BMI of 27 or greater who have weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea Individuals who have not achieved adequate results with semaglutide or tirzepatide Patients seeking greater weight loss than what current medications provide Individuals with metabolic dysfunction-associated steatohepatitis (MASH) given the glucagon receptors role in liver fat metabolism Retatrutide may not be appropriate for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastrointestinal disorders, or a history of pancreatitis

Daily targets: Sodium: 1,500-2,000mg from food and supplementation Potassium: 3,500-4,700mg primarily from food Magnesium glycinate: 200-300mg supplemental Calcium citrate: 500-600mg supplemental (if dietary intake is low) Vitamin D: 1,000 IU daily Implementation: Morning: magnesium glycinate (200mg) with breakfast Midday: electrolyte drink mix (one serving) or bone broth Evening: calcium citrate (500mg) with vitamin D at dinner Focus on potassium-rich foods at every meal This protocol covers the basics